The United States represents the largest share of the viral vector and plasmid DNA manufacturing market, driven by its strong biotechnology ecosystem, substantial research funding, and leadership in gene and cell therapy development. The country is home to numerous biotechnology companies, academic research institutions, and contract development and manufacturing organizations (CDMOs) that are...